Buscar
Mostrando ítems 31-40 de 135
Exploring structure-based drug design for the development of multi-target antihypertensives
(Bentham Science Publishers, 2020)
LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats
(Elsevier B.V., 2018-04-01)
Bradykinin-potentiating peptides (BPPs) are an important group of toxins present in Lachesis muta rhombeata venom. They act directly at renin-angiotensin-aldosterone system, through the inhibition of angiotensin-converting ...
Pronóstico de los pacientes hospitalizados por Covid-19 que utilizaban inhibidores de la enzima convertidora de angiotensina o antagonistas del receptor de angiotensina II
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2021-03-08)
Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro
(Lippincott Williams and Wilkins, 2010)
Background: Angiotensin-(1-9) is present in human and rat plasma and its circulating levels increased early after myocardial infarction or in animals treated with angiotensin-converting enzyme inhibitor. However, the ...
Angiotensin II Binding to Angiotensin I-Converting Enzyme Triggers Calcium Signaling
(LIPPINCOTT WILLIAMS & WILKINS, 2011)
Angiotensin (Ang) I-converting enzyme (ACE) is involved in the control of blood pressure by catalyzing the conversion of Ang I into the vasoconstrictor Ang II and degrading the vasodilator peptide bradykinin. Human ACE ...
NIFEDIPINE PREVENTS RENAL INJURY IN RATS WITH CHRONIC NITRIC-OXIDE INHIBITION
(Amer Heart AssocDallas, 1995)
Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats
(Pergamon PressOxford, 2013-07-10)
Aims: Angiotensin-converting enzyme (ACE) inhibitors are used in diabetic kidney disease to reduce systemic/intra-glomerular pressure. The objective of this study was to investigate whether reducing blood pressure (BP) ...
Are the current chronic allograft nephropathy grading systems sufficient to predict renal allograft survival?
(Associação Brasileira de Divulgação Científica, 2008-10-01)
A major problem in renal transplantation is identifying a grading system that can predict long-term graft survival. The present study determined the extent to which the two existing grading systems (Banff 97 and chronic ...